156 related articles for article (PubMed ID: 2997262)
41. Signaling pathways involved in atrial natriuretic factor and dopamine regulation of renal Na+, K+ -ATPase activity.
Correa AH; Choi MR; Gironacci M; Valera MS; Fernández BE
Regul Pept; 2007 Jan; 138(1):26-31. PubMed ID: 17005263
[TBL] [Abstract][Full Text] [Related]
42. Reduced plasma cyclic GMP but normal renal responses to atrial natriuretic factor in pre-hypertension.
Ferrari P; Gadient G; Cozzio A; Shaw S; Weidmann P
Blood Press; 1996 Jan; 5(1):16-26. PubMed ID: 8777468
[TBL] [Abstract][Full Text] [Related]
43. Atrial natriuretic peptide-cyclic GMP relationships in normal humans: effects of dietary sodium intake.
Sagnella GA; Markandu ND; Buckley MG; Singer DR; MacGregor GA
Clin Sci (Lond); 1993 Jul; 85(1):13-7. PubMed ID: 8149688
[TBL] [Abstract][Full Text] [Related]
44. The role of atrial natriuretic factor [alpha-human ANF-(99-126)] in the hormonal and renal adaptation to sodium deficiency.
Beland B; Tuchelt H; Bähr V; Oelkers W
J Clin Endocrinol Metab; 1994 Jul; 79(1):183-8. PubMed ID: 8027224
[TBL] [Abstract][Full Text] [Related]
45. Renal effects of TAPP, a highly selective mu-opioid agonist.
Gutkowska J; Schiller PW
Br J Pharmacol; 1996 Sep; 119(2):239-44. PubMed ID: 8886404
[TBL] [Abstract][Full Text] [Related]
46. Effects of atrial natriuretic factor on anterior pituitary hormone secretion in normal man.
Kentsch M; Lawrenz R; Ball P; Gerzer R; Müller-Esch G
Clin Investig; 1992 Jul; 70(7):549-55. PubMed ID: 1392423
[TBL] [Abstract][Full Text] [Related]
47. Kinetics of plasma cyclic GMP and atrial natriuretic peptide after intravenous, intramuscular and subcutaneous injection of 50 micrograms hANP in man.
Osterode W; Nowotny P; Vierhapper H; Waldhäusl W
Horm Metab Res; 1995 Feb; 27(2):100-3. PubMed ID: 7759055
[TBL] [Abstract][Full Text] [Related]
48. Alpha-human atrial natriuretic polypeptide-induced rise of plasma and urinary cyclic 3'5'-guanosine monophosphate concentration in human subjects.
Ohashi M; Fujio N; Nawata H; Kato K; Ibayashi H
Clin Exp Hypertens A; 1986; 8(1):67-73. PubMed ID: 3011321
[TBL] [Abstract][Full Text] [Related]
49. Atrial natriuretic peptides and cyclic guanosine monophosphate metabolism.
Vesely DL; Giordano AT; Douglass MA; McCormick MT; Rodriguez-Paz G; Schocken DD
Am J Med Sci; 1995 Oct; 310(4):143-9. PubMed ID: 7573117
[TBL] [Abstract][Full Text] [Related]
50. Atrial natriuretic peptide and renal cGMP in rats with experimental heart failure.
Abassi Z; Burnett JC; Grushka E; Hoffman A; Haramati A; Winaver J
Am J Physiol; 1991 Oct; 261(4 Pt 2):R858-64. PubMed ID: 1656791
[TBL] [Abstract][Full Text] [Related]
51. Glucocorticoids potentiate the action of atrial natriuretic polypeptide in adrenalectomized rats.
Hayamizu S; Kanda K; Ohmori S; Murata Y; Seo H
Endocrinology; 1994 Dec; 135(6):2459-64. PubMed ID: 7988432
[TBL] [Abstract][Full Text] [Related]
52. Atrial natriuretic factor counteracts sodium-retaining actions of insulin in normal men.
Miller JA; Abouchacra S; Zinman B; Skorecki KL; Logan AG
Am J Physiol; 1993 Sep; 265(3 Pt 2):R584-90. PubMed ID: 8214150
[TBL] [Abstract][Full Text] [Related]
53. Urinary cyclic guanosine monophosphate as an indicator of experimental congestive heart failure in rats.
Michel JB; Mercadier JJ; Galen FX; Urbain R; Dussaule JC; Philippe M; Corvol P
Cardiovasc Res; 1990 Nov; 24(11):946-52. PubMed ID: 2176935
[TBL] [Abstract][Full Text] [Related]
54. The peripheral action of clonidine analog ST-91: involvement of atrial natriuretic factor.
Gutkowska J; Mukaddam-Daher S; Tremblay J
J Pharmacol Exp Ther; 1997 May; 281(2):670-6. PubMed ID: 9152372
[TBL] [Abstract][Full Text] [Related]
55. [Effect of sinorphan, an endopeptidase inhibitor on severe congestive cardiac insufficiency].
Varin J; Duboc D; Weber S; Fouchard J; Schwartz JC; Muffat-Joly M; Guérin F
Arch Mal Coeur Vaiss; 1991 Oct; 84(10):1465-71. PubMed ID: 1662033
[TBL] [Abstract][Full Text] [Related]
56. Prolonged administration of human atrial natriuretic peptide in healthy men: evanescent effects on diuresis and natriuresis.
Waldhäusl W; Vierhapper H; Nowotny P
J Clin Endocrinol Metab; 1986 May; 62(5):956-9. PubMed ID: 2937802
[TBL] [Abstract][Full Text] [Related]
57. Haemodynamic and renal effects of urodilatin bolus injections in patients with congestive heart failure.
Kentsch M; Ludwig D; Drummer C; Gerzer R; Müller-Esch G
Eur J Clin Invest; 1992 Oct; 22(10):662-9. PubMed ID: 1333960
[TBL] [Abstract][Full Text] [Related]
58. Metoclopramide does not inhibit atrial natriuretic factor-stimulated diuresis in man.
Farrow S; Mahayni A; Banta G; Sowers J; Lockette W
Aviat Space Environ Med; 1996 Mar; 67(3):248-52. PubMed ID: 8775403
[TBL] [Abstract][Full Text] [Related]
59. Atrial natriuretic factor: radioimmunoassay and effects on adrenal and pituitary glands.
Gutkowska J; Horký K; Schiffrin EL; Thibault G; Garcia R; De Léan GA; Hamet P; Tremblay J; Anand-Srivastava MB; Januszewicz P
Fed Proc; 1986 Jun; 45(7):2101-5. PubMed ID: 2872084
[TBL] [Abstract][Full Text] [Related]
60. Atrial natriuretic factor influences in vivo plasma, lung and aortic wall cGMP concentrations differently.
Arnal JF; el Amrani AI; Michel JB
Eur J Pharmacol; 1993 Jun; 237(2-3):265-73. PubMed ID: 8396039
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
